{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:38:19Z","timestamp":1793036299842,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.parkreldis.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:16:14Z","timestamp":1468800974000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"special_numbering":"C","title":["Pharmacological treatment in Parkinson's disease: Effects on gait"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-5277","authenticated-orcid":false,"given":"Katrijn","family":"Smulders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian L.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Carlson-Kuhta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay B.","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.07.006_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroscience.2014.01.041","article-title":"The nature of dual-task interference during gait in incident Parkinson's disease","volume":"265","author":"Rochester","year":"2014","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1460-9568.2006.05033.x","article-title":"Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease","volume":"24","author":"Baltadjieva","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gaitpost.2007.08.003","article-title":"Relationships between gait and dynamic balance in early Parkinson's disease","volume":"27","author":"Yang","year":"2008","journal-title":"Gait Posture"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp.2009.173740","article-title":"The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease","volume":"81","author":"Zampieri","year":"2010","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.wco.0000137530.68867.93","article-title":"Falls in Parkinson's disease","volume":"17","author":"Grimbergen","year":"2004","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.26110","article-title":"Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype","volume":"30","author":"Galna","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2016.04.029","article-title":"Progression of postural control and gait deficits in Parkinson's disease and freezing of gait: a longitudinal study","volume":"28","author":"Vervoort","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib8","first-page":"108","article-title":"The major impact of freezing of gait on quality of life in Parkinson's disease","volume":"262","author":"Walton","year":"2015","journal-title":"J.\u00a0Neurol."},{"issue":"23","key":"10.1016\/j.parkreldis.2016.07.006_bib9","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","article-title":"Determinants of disability and quality of life in mild to moderate Parkinson disease","volume":"70","author":"Muslimovic","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.humov.2006.03.004","article-title":"Relationships between dual-task related changes in stride velocity and stride time variability in healthy older adults","volume":"25","author":"Dubost","year":"2006","journal-title":"Hum. Mov. Sci."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.12.016","article-title":"Effect of type of cognitive task and walking speed on cognitive-motor interference during dual-task walking","volume":"260","author":"Patel","year":"2014","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00702-016-1516-7","article-title":"Secondary task performance during challenging walking tasks and freezing episodes in Parkinson's disease","volume":"123","author":"Dibilio","year":"2016","journal-title":"J.\u00a0Neural Transm."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/NRE-151236","article-title":"Continuous monitoring of turning in Parkinson's disease: rehabilitation potential","volume":"37","author":"Mancini","year":"2015","journal-title":"NeuroRehabilitation"},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s002210050932","article-title":"Online steering: coordination and control of body center of mass, head and body reorientation","volume":"129","author":"Patla","year":"1999","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12984-016-0147-4","article-title":"The quality of turning in Parkinson's disease: a compensatory strategy to prevent postural instability?","volume":"13","author":"Mellone","year":"2016","journal-title":"J.\u00a0Neuroeng. Rehabil."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gaitpost.2012.02.002","article-title":"Community-dwelling people with chronic stroke need disproportionate attention while walking and negotiating obstacles","volume":"36","author":"Smulders","year":"2012","journal-title":"Gait Posture"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00222890309602121","article-title":"Distraction affects the performance of obstacle avoidance during walking","volume":"35","author":"Weerdesteyn","year":"2003","journal-title":"J.\u00a0Mot. Behav."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.gaitpost.2012.02.024","article-title":"Dual-tasking interferes with obstacle avoidance reactions in healthy seniors","volume":"36","author":"Hegeman","year":"2012","journal-title":"Gait Posture"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2016.07.006_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/brain\/117.5.1169","article-title":"The pathogenesis of gait hypokinesia in Parkinson's disease","volume":"117","author":"Morris","year":"1994","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.parkreldis.2016.07.006_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1136\/jnnp.57.12.1532","article-title":"Ability to modulate walking cadence remains intact in Parkinson's disease","volume":"57","author":"Morris","year":"1994","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mds.870120211","article-title":"Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers","volume":"12","author":"Burleigh-Jacobs","year":"1997","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/003655099444533","article-title":"Plantar force distribution in Parkinsonian gait: a comparison between patients and age-matched control subjects","volume":"31","author":"Nieuwboer","year":"1999","journal-title":"Scand. J. Rehabil. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2125.1990.tb03738.x","article-title":"Determinants of gait in the elderly parkinsonian on maintenance levodopa\/carbidopa therapy","volume":"30","author":"Bowes","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JPD-140447","article-title":"Dopaminergic modulation of arm swing during gait among Parkinson's disease patients","volume":"5","author":"Sterling","year":"2015","journal-title":"J.\u00a0Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1743-0003-2-19","article-title":"Gait variability: methods, modeling and meaning","volume":"2","author":"Hausdorff","year":"2005","journal-title":"J.\u00a0Neuroeng. Rehabil."},{"issue":"3\u20134","key":"10.1016\/j.parkreldis.2016.07.006_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00221-011-2551-0","article-title":"Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the \u201cON\u201d medication state","volume":"210","author":"Plotnik","year":"2011","journal-title":"Exp. Brain Res."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib27","doi-asserted-by":"crossref","first-page":"e96675","DOI":"10.1371\/journal.pone.0096675","article-title":"Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days","volume":"9","author":"Weiss","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.parkreldis.2016.07.006_bib28","first-page":"1840","article-title":"Assessment of dual tasking has no clinical value for fall prediction in Parkinson's disease","volume":"259","author":"Smulders","year":"2012","journal-title":"J.\u00a0Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2008.10.019","article-title":"Knee trembling during freezing of gait represents multiple anticipatory postural adjustments","volume":"215","author":"Jacobs","year":"2009","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/mds.870120509","article-title":"Gait initiation in Parkinson's disease","volume":"12","author":"Rosin","year":"1997","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.gaitpost.2012.01.018","article-title":"Spatiotemporal variability during gait initiation in Parkinson's disease","volume":"36","author":"Roemmich","year":"2012","journal-title":"Gait Posture"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.gaitpost.2012.07.018","article-title":"Age and Parkinson's disease related kinematic alterations during multi-directional gait initiation","volume":"37","author":"Vallabhajosula","year":"2013","journal-title":"Gait Posture"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2016.07.006_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2006.07.027","article-title":"Step initiation in Parkinson's disease: influence of initial stance conditions","volume":"406","author":"Rocchi","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.gaitpost.2007.04.010","article-title":"The association between impaired turning and normal straight walking in Parkinson's disease","volume":"26","author":"Crenna","year":"2007","journal-title":"Gait Posture"},{"issue":"10","key":"10.1016\/j.parkreldis.2016.07.006_bib35","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.21943","article-title":"Head and trunk rotation during walking turns in Parkinson's disease","volume":"23","author":"Huxham","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"7","key":"10.1016\/j.parkreldis.2016.07.006_bib36","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.clinph.2007.03.010","article-title":"Quantification of trunk rotations during turning and walking in Parkinson's disease","volume":"118","author":"Visser","year":"2007","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gaitpost.2013.07.128","article-title":"Sequence and onset of whole-body coordination when turning in response to a visual trigger: comparing people with Parkinson's disease and healthy adults","volume":"39","author":"Ashburn","year":"2014","journal-title":"Gait posture"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.expneurol.2009.06.013","article-title":"Reduced performance in balance, walking and turning tasks is associated with increased neck tone in Parkinson's disease","volume":"219","author":"Franzen","year":"2009","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1545968308320639","article-title":"A\u00a0kinematic and electromyographic analysis of turning in people with Parkinson disease","volume":"23","author":"Hong","year":"2009","journal-title":"Neurorehabil. Neural Repair"},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/mds.21932","article-title":"Footstep adjustments used to turn during walking in Parkinson's disease","volume":"23","author":"Huxham","year":"2008","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.parkreldis.2016.07.006_bib41","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1080\/09638280701829938","article-title":"Dysfunctional turning in Parkinson's disease","volume":"30","author":"Stack","year":"2008","journal-title":"Disabil. Rehabil."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gaitpost.2014.03.003","article-title":"Disease severity affects obstacle crossing in people with Parkinson's disease","volume":"40","author":"Vitorio","year":"2014","journal-title":"Gait Posture"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gaitpost.2012.12.019","article-title":"Influence of visual feedback sampling on obstacle crossing behavior in people with Parkinson's disease","volume":"38","author":"Vitorio","year":"2013","journal-title":"Gait Posture"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humov.2009.09.006","article-title":"Obstacle crossing in people with Parkinson's disease: foot clearance and spatiotemporal deficits","volume":"29","author":"Galna","year":"2010","journal-title":"Hum. Mov. Sci."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib45","first-page":"787861","article-title":"Obstacle avoidance amongst Parkinson disease patients is challenged in a threatening context","volume":"2013","author":"Doan","year":"2013","journal-title":"J.\u00a0Neurodegener. Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib46","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.gaitpost.2013.03.024","article-title":"Obstacle crossing in Parkinson's disease: mediolateral sway of the centre of mass during level-ground walking and obstacle crossing","volume":"38","author":"Galna","year":"2013","journal-title":"Gait Posture"},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.apmr.2011.11.004","article-title":"Postural instability and gait impairment during obstacle crossing in Parkinson's disease","volume":"93","author":"Stegemoller","year":"2012","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.parkreldis.2014.12.020","article-title":"A\u00a012-year population-based study of freezing of gait in Parkinson's disease","volume":"21","author":"Forsaa","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2011-300869","article-title":"The relationship between motor planning and freezing of gait in Parkinson's disease","volume":"83","author":"Knobl","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.parkreldis.2016.07.006_bib50","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jnnp-2014-308840","article-title":"Dual-task interference and brain structural connectivity in people with Parkinson's disease who freeze","volume":"86","author":"Peterson","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.parkreldis.2016.07.006_bib51","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.parkreldis.2013.04.004","article-title":"Levodopa changes the severity of freezing in Parkinson's disease","volume":"19","author":"Fietzek","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib52","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ana.20452","article-title":"Is freezing of gait in Parkinson's disease related to asymmetric motor function?","volume":"57","author":"Plotnik","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gaitpost.2015.10.021","article-title":"Center of mass trajectories during turning in patients with Parkinson's disease with and without freezing of gait","volume":"43","author":"Bengevoord","year":"2016","journal-title":"Gait Posture"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0966-6362(01)00156-4","article-title":"Attention and the control of posture and gait: a review of an emerging area of research","volume":"16","author":"Woollacott","year":"2002","journal-title":"Gait Posture"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib55","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1460-9568.2005.04298.x","article-title":"Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding?","volume":"22","author":"Yogev","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"15","key":"10.1016\/j.parkreldis.2016.07.006_bib56","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/mds.23327","article-title":"Freezing of gait in Parkinson's disease: the impact of dual-tasking and turning","volume":"25","author":"Spildooren","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000096490","article-title":"Immediate placebo effect in Parkinson's disease\u2013is the subjective relief accompanied by objective improvement?","volume":"56","author":"Fregni","year":"2006","journal-title":"Eur. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mds.23450","article-title":"Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues","volume":"26","author":"Rochester","year":"2011","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.07.006_bib59","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.26269","article-title":"Levodopa is a double-edged Sword for balance and gait in people with Parkinson's disease","volume":"30","author":"Curtze","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-510X(91)90283-D","article-title":"Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease","volume":"103","author":"Blin","year":"1991","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"9","key":"10.1016\/j.parkreldis.2016.07.006_bib61","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1179\/1743132811Y.0000000044","article-title":"Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment","volume":"33","author":"Bryant","year":"2011","journal-title":"Neurol. Res."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib62","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cger.2006.06.009","article-title":"Postural control, gait, and dopamine functions in parkinsonian movement disorders","volume":"22","author":"Bohnen","year":"2006","journal-title":"Clin. Geriatr. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib63","first-page":"11","article-title":"Effects of medication on turning deficits in individuals with Parkinson's disease, Journal of neurologic physical therapy","volume":"34","author":"Hong","year":"2010","journal-title":"JNPT"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib64","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00222895.2013.810139","article-title":"Evaluating the acute contributions of dopaminergic replacement to gait with obstacles in Parkinson's disease","volume":"45","author":"Pieruccini-Faria","year":"2013","journal-title":"J.\u00a0Mot. Behav."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib65","first-page":"330","article-title":"Gait and upper limb variability in Parkinson's disease patients with and without freezing of gait","volume":"261","author":"Barbe","year":"2014","journal-title":"J.\u00a0Neurol."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2016.07.006_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(03)00104-7","article-title":"Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa","volume":"212","author":"Schaafsma","year":"2003","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"7","key":"10.1016\/j.parkreldis.2016.07.006_bib67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1212\/WNL.0b013e3182477ec0","article-title":"\u201cOn\u201d state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication","volume":"78","author":"Espay","year":"2012","journal-title":"Neurology"},{"issue":"Suppl 4","key":"10.1016\/j.parkreldis.2016.07.006_bib68","first-page":"IV37","article-title":"Does levodopa slow or hasten the rate of progression of Parkinson's disease?","volume":"252","author":"Fahn","year":"2005","journal-title":"J.\u00a0Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.parkreldis.2014.12.019","article-title":"24 h Levodopa-carbidopa intestinal gel may reduce falls and \u201cunresponsive\u201d freezing of gait in Parkinson's disease","volume":"21","author":"Chang","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"Suppl 3","key":"10.1016\/j.parkreldis.2016.07.006_bib70","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.23829","article-title":"The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease","volume":"26","author":"Fox","year":"2011","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2016.07.006_bib71","first-page":"2539","article-title":"Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study","volume":"262","author":"Serrao","year":"2015","journal-title":"J.\u00a0Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199901000-00001","article-title":"Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease","volume":"22","author":"Ondo","year":"1999","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archneurol.2009.287","article-title":"Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease","volume":"67","author":"Brodsky","year":"2010","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mds.870090107","article-title":"A\u00a0multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease","volume":"9","author":"Olanow","year":"1994","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00002826-199901000-00005","article-title":"Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease","volume":"22","author":"Napolitano","year":"1999","journal-title":"Clin. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.07.006_bib76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1353-8020(00)00019-5","article-title":"The pharmacokinetic and clinical effects of tolcapone on a single dose of sublingual apomorphine in Parkinson's disease","volume":"6","author":"Ondo","year":"2000","journal-title":"Park. Relat. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.07.006_bib77","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/archneur.1989.00520460028009","article-title":"DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group","volume":"46","author":"Group","year":"1989","journal-title":"Arch. Neurol."},{"issue":"13","key":"10.1016\/j.parkreldis.2016.07.006_bib78","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A\u00a0double-blind, delayed-start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3 Suppl 1","key":"10.1016\/j.parkreldis.2016.07.006_bib79","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1002\/ana.410440724","article-title":"DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism","volume":"44","author":"Shoulson","year":"1998","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2016.07.006_bib80","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.56.12.1712","article-title":"Freezing of gait in PD: prospective assessment in the DATATOP cohort","volume":"56","author":"Giladi","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib81","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.parkreldis.2014.02.024","article-title":"Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial","volume":"20","author":"Jankovic","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-199302000-00010","article-title":"Effects of selegiline dosing on motor fluctuations in Parkinson's disease","volume":"16","author":"Hubble","year":"1993","journal-title":"Clin. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.parkreldis.2016.07.006_bib83","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/phar.1611","article-title":"Clinical outcomes in patients with Parkinson's disease treated with a monoamine oxidase Type-B inhibitor: a cross-sectional, cohort study","volume":"35","author":"Dashtipour","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WNF.0b013e31826e3406","article-title":"Amantadine for freezing of gait in patients with Parkinson disease","volume":"35","author":"Malkani","year":"2012","journal-title":"Clin. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.parkreldis.2016.07.006_bib85","first-page":"3030","article-title":"Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial","volume":"260","author":"Lee","year":"2013","journal-title":"J.\u00a0Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2016.07.006_bib86","doi-asserted-by":"crossref","first-page":"e48890","DOI":"10.1371\/journal.pone.0048890","article-title":"Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2012.11.005","article-title":"Amantadine improves gait in PD patients with STN stimulation","volume":"19","author":"Chan","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2377-13-184","article-title":"Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study","volume":"13","author":"Beauchet","year":"2013","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib89","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp-2012-303182","article-title":"Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study","volume":"84","author":"Moreau","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"18","key":"10.1016\/j.parkreldis.2016.07.006_bib90","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","article-title":"Gait speed in Parkinson disease correlates with cholinergic degeneration","volume":"81","author":"Bohnen","year":"2013","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.parkreldis.2016.07.006_bib91","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in Parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2016.07.006_bib92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinson's disease","volume":"13","author":"Muller","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"Pt 9","key":"10.1016\/j.parkreldis.2016.07.006_bib93","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/brain\/aws207","article-title":"Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease","volume":"135","author":"Rochester","year":"2012","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.parkreldis.2016.07.006_bib94","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00221-013-3737-4","article-title":"The ability of people with Parkinson's disease to modify dual-task performance in response to instructions during simple and complex walking tasks","volume":"232","author":"Kelly","year":"2014","journal-title":"Exp. Brain Res."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib96","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2522\/ptj.20130251","article-title":"Associations between cognitive and gait performance during single- and dual-task walking in people with Parkinson disease","volume":"94","author":"Stegemoller","year":"2014","journal-title":"Phys. Ther."},{"issue":"24","key":"10.1016\/j.parkreldis.2016.07.006_bib97","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"14","key":"10.1016\/j.parkreldis.2016.07.006_bib98","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","article-title":"Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease","volume":"75","author":"Chung","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1532-5415.2008.01657.x","article-title":"Galantamine improves gait performance in patients with Alzheimer's disease","volume":"56","author":"Assal","year":"2008","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.07.006_bib100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2174\/1567205012666150710111341","article-title":"Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis","volume":"12","author":"Beauchet","year":"2015","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-140759","article-title":"Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial","volume":"43","author":"Montero-Odasso","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Henderson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib103","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2377-13-188","article-title":"The ReSPonD trial\u2013rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen","volume":"13","author":"Henderson","year":"2013","journal-title":"BMC Neurol."},{"issue":"B","key":"10.1016\/j.parkreldis.2016.07.006_bib104","first-page":"351","article-title":"L-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism","volume":"57","author":"Narabayashi","year":"1982","journal-title":"Proc. Jpn. Acad."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02260912","article-title":"The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients","volume":"5","author":"Tohgi","year":"1993","journal-title":"J.\u00a0Neural Transm. Park. Dis. Dement. Sect."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mehy.2012.11.031","article-title":"L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease","volume":"80","author":"Fukada","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.parkreldis.2016.07.006_bib107","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib108","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib109","first-page":"CD009885","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","volume":"11","author":"Storebo","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002826-200601000-00005","article-title":"Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study","volume":"29","author":"Auriel","year":"2006","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib111","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archneur.64.3.319","article-title":"Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial","volume":"64","author":"Nutt","year":"2007","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib112","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp.2006.100016","article-title":"Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson\u2019s disease","volume":"78","author":"Devos","year":"2007","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib113","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.gaitpost.2014.10.022","article-title":"Gait and attentional performance in freezers under methylphenidate","volume":"41","author":"Delval","year":"2015","journal-title":"Gait Posture"},{"issue":"14","key":"10.1016\/j.parkreldis.2016.07.006_bib114","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.0b013e3182143537","article-title":"Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial","volume":"76","author":"Espay","year":"2011","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.parkreldis.2016.07.006_bib115","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.parkreldis.2016.07.006_bib116","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJM199809243391303","article-title":"Antidepressants and the risk of falls among nursing home residents","volume":"339","author":"Thapa","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib117","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nedt.2013.05.016","article-title":"Medication fall risk in old hospitalized patients: a retrospective study","volume":"34","author":"Costa-Dias","year":"2014","journal-title":"Nurse Educ. Today"},{"key":"10.1016\/j.parkreldis.2016.07.006_bib119","doi-asserted-by":"crossref","DOI":"10.1097\/PTS.0000000000000163","article-title":"Medications and patient characteristics associated with falling in the hospital","author":"O'Neil","year":"2015","journal-title":"J.\u00a0Patient Saf."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1525-1497.2005.40171.x","article-title":"A\u00a0case-control study of patient, medication, and care-related risk factors for inpatient falls","volume":"20","author":"Krauss","year":"2005","journal-title":"J.\u00a0Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib122","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/JCP.0b013e3182485802","article-title":"Sedative load among community-dwelling people aged 75 years or older: association with balance and mobility","volume":"32","author":"Taipale","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.07.006_bib123","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/WNF.0b013e31823337d1","article-title":"Unraveling the association between SSRI use and falls: an experimental study of risk factors for accidental falls in long-term paroxetine users","volume":"34","author":"Hegeman","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib124","doi-asserted-by":"crossref","first-page":"M36","DOI":"10.1093\/gerona\/56.1.M36","article-title":"The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people","volume":"56","author":"Draganich","year":"2001","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JPD-2012-012101","article-title":"Treating orthostatic hypotension in patients with Parkinson's disease and atypical Parkinsonism improves function","volume":"2","author":"Hohler","year":"2012","journal-title":"J.\u00a0Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/gerona\/62.1.83","article-title":"Serum anticholinergic activity and motor performance in elderly persons","volume":"62","author":"Nebes","year":"2007","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.07.006_bib127","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1041610202008505","article-title":"Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study","volume":"14","author":"Aizenberg","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1756-0500-3-243","article-title":"Even low alcohol concentrations affect obstacle avoidance reactions in healthy senior individuals","volume":"3","author":"Hegeman","year":"2010","journal-title":"BMC Res. Notes"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.07.006_bib129","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.alcohol.2008.04.004","article-title":"The contribution of alcohol to falls at home among working-aged adults","volume":"42","author":"Kool","year":"2008","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.07.006_bib130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/WNL.0b013e3181e7b688","article-title":"Predictors of future falls in Parkinson disease","volume":"75","author":"Kerr","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2016.07.006_bib131","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/mds.22561","article-title":"Clinical and physiological assessments for elucidating falls risk in Parkinson's disease","volume":"24","author":"Latt","year":"2009","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2016.07.006_bib132","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/gerona\/gls255","article-title":"Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach","volume":"68","author":"Lord","year":"2013","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib133","doi-asserted-by":"crossref","DOI":"10.2522\/ptj.20150580","article-title":"Independent domains of mobility in Parkinson disease","author":"Horak","year":"2016","journal-title":"Phys. Ther."},{"key":"10.1016\/j.parkreldis.2016.07.006_bib134","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12883-015-0474-2","article-title":"Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: a randomized clinical trial","volume":"15","author":"King","year":"2015","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.07.006_bib135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12883-015-0523-x","article-title":"Effect of augmenting cholinergic function on gait and balance","volume":"15","author":"Mancini","year":"2015","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2016.07.006_bib136","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11055-008-9077-3","article-title":"Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson\u2019s disease (an open controlled trial)","volume":"38","author":"Litvinenko","year":"2008","journal-title":"Neurosci. Behav. Physiol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016302632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016302632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:42:48Z","timestamp":1656812568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016302632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":136,"alternative-id":["S1353802016302632"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.006","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment in Parkinson's disease: Effects on gait","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}